In an oncolytic virotherapy study using decorin, Choi et al. showed that tumor tissue dispersion by decorin-expressing oncolytic Ad was substantially enhanced compared with that of control oncolytic Ad, in tumor spheroids prepared from glioma or breast cancer patients as well as established subcutaneous human glioma xenograft tumors in vivo (158). This evidence concerns the gene DCN and breast carcinoma.